trending Market Intelligence /marketintelligence/en/news-insights/trending/umwlngittmdrxq-lwkhjzg2 content esgSubNav
In This List

Pfizer elects board member

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Pfizer elects board member

Pfizer Inc. elected Dan Littman to the board.

Littman is a professor of molecular immunology at Skirball Institute of Biomolecular Medicine of NYU Langone Medical Center and an investigator of the Howard Hughes Medical Institute.